Management of chronic spontaneous urticaria in routine clinical practice: a Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
Allergol. immunopatol
; 45(2): 134-144, mar.-abr. 2017. tab
Artículo
en Inglés
| IBECS
| ID: ibc-160518
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
BACKGROUND:
Chronic spontaneous urticaria (CSU) is a frequent clinical entity that often presents a diagnostic and therapeutic challenge.OBJECTIVE:
To explore the degree of agreement that exists among the experts caring for patients with CSU diagnosis, evaluation, and management.METHODS:
An online survey was conducted to explore the opinions of experts in CSU, address controversial issues, and provide recommendations regarding its definition, natural history, diagnosis, and treatment. A modified Delphi method was used for the consensus.RESULTS:
The questionnaire was answered by 68 experts (dermatologists, allergologists, and primary care physicians). A consensus was reached on 54 of the 65 items posed (96.4%). The experts concluded that CSU is a difficult-to-control disease of unpredictable evolution. Diagnostic tests should be limited and based on clinical history and should not be indiscriminate. Autoinflammatory syndromes and urticarial vasculitis must be ruled out in the differential diagnosis. A cutaneous biopsy is only recommended when wheals last more than 24h, to rule out urticarial vasculitis. The use of specific scales to assess the severity of the disease and the quality of life is recommended. In patients with severe and resistant CSU, second-generation H1-antihistamines could be used at doses up to four times the standard dose before giving second-line treatments. Omalizumab is a safe and effective treatment for CSU that is refractory to H1-antihistamines treatment. In general, diagnosis and treatment recommendations given for adults could be extrapolated to children.CONCLUSIONS:
This work offers consensus recommendations that may be useful in the management of CSURESUMEN
No disponible
Buscar en Google
Colección:
Bases de datos nacionales
/
España
Base de datos:
IBECS
Asunto principal:
Urticaria
/
Enfermedad Crónica
/
Omalizumab
/
Angioedema
Tipo de estudio:
Guía de práctica clínica
Aspecto:
Preferencia del paciente
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Allergol. immunopatol
Año:
2017
Tipo del documento:
Artículo
Institución/País de afiliación:
Allergology Department/Spain
/
Fundación Jiménez Diaz/Spain
/
Hospital Arnau de Vilanova/Spain
/
Hospital Clinic (ICT)/Spain
/
Hospital Clinic/Spain
/
Hospital General Universitario de Alicante/Spain
/
Hospital Universitario 12 de Octubre/Spain
/
Hospital Universitario Basurto/Spain
/
Hospital Vall dHebron/Spain
/
Parc de Salut Mar/Spain